+499.5%
MRNA vs VMC
-8.5%
+508.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.9% | -3.2% | -2.9% |
| 7D | +5.5% | -4.3% | +9.8% | +8.5% |
| 30D | +158.7% | -8.2% | +167.0% | +171.9% |
| 3M | +182.1% | -7.0% | +189.2% | +193.7% |
| 6M | +151.8% | -10.8% | +162.6% | +163.7% |
| YTD | +393.6% | -7.4% | +400.9% | +388.5% |
| 1Y | +499.5% | -9.5% | +509.0% | +495.8% |
| All | +499.5% | -8.5% | +508.0% | +495.8% |
Cumulative growth
Daily Returns
Daily percentage return beside VMC.
Daily Out/Under-Performance
Portfolio return minus VMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling